NASDAQ · Medical - Devices

APYX (APYX) Stock

$4.07 -1.21% NASDAQ: APYX Healthcare

Valuation

MetricValue
Price$4.07
Market Cap$171.39M
P/E Ratio-17.90
P/B Ratio15.36
P/S Ratio3.50
EPS (TTM)$0.00
52-Week High$5.08
52-Week Low$1.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-76.49%
ROA-4.37%
ROCE-40.00%
Gross Margin32.27%
Operating Margin-7.70%
Net Margin-16.40%
Debt/Equity3.08
Current Ratio4.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$49.0M$45.0M$52.0M$48.0M$53.0M
Operating Profit$-14.0M$-24.0M$-17.0M$-19.0M$-6.0M
Net Profit$-15.0M$-23.0M$-19.0M$-23.0M$-11.0M
EPS$-0.44$-0.67$-0.54$-0.66$-0.27
Op Margin-29.8%-52.9%-33.0%-39.2%-12.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$69.0M$52.0M$79.0M$65.0M$67.0M
Total Liabilities$15.0M$14.0M$52.0M$51.0M$52.0M
Cash$31.0M$10.0M$44.0M$32.0M$32.0M
Borrowings$0$1.0M$39.0M$39.0M$39.0M

Latest News

HC Wainwright Initiates Apyx Medical at Buy With $7 Price Target MT Newswires · Jul 13, 2026 Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity Insider Monkey · Jun 19, 2026 How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals Simply Wall St. · Jun 1, 2026 Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire · May 27, 2026 What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play Motley Fool · May 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-20.0M$-5.0M$-18.0M$-8.0M
Investing Cash Flow$-1.0M$-2.0M$6.0M$-1.0M$-2.0M
Financing Cash Flow$0$0$-6.0M$0$0
Net Cash Flow$-11.0M$-21.0M$33.0M$-12.0M$0
Free Cash Flow$-11.0M$-21.0M$-6.0M$-19.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.59
EV / EBITDA-57.14
FCF Yield-4.60%
Quick Ratio4.79
Interest Coverage-1.00
Return 1Y114.21%
Return 3Y-30.13%
Return 5Y-53.83%

Ownership

Insiders Held13.61%
Institutions Held49.60%
Institutions Float Held57.42%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC3,440,3042026-03-31
Archon Capital Management LLC2,790,9232026-03-31
Royce & Associates LP2,611,2242026-03-31
Vanguard Capital Management LLC1,555,2722026-03-31
AIGH Capital Management LLC1,104,9702026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATOS $2.36 -2.48% -1.23 $23.54M 0.00%
LUCD $0.97 +1.47% -1.45 $98.94M 0.00%
NSPR $0.69 +0.87% -1.21 $32.30M 0.00%
PDEX $63.61 +8.61% 17.11 $203.09M 0.00%
QIPTQuipt Home Medical Corp. $3.65 +0.00% -14.85 $162.30M 0.00%

About APYX

APYX is led by CEO Charles D. Goodwin, employs 220 people, headquartered in US, publicly traded since 2019.

APYX stock trades at $4.07 with a market capitalization of $171.39M. The stock is valued at a price-to-earnings (P/E) ratio of -17.90, price-to-book of 15.36, price-to-sales of 3.50. Over the past 52 weeks the stock has ranged between $1.59 and $5.08, and currently trades 19.9% below its 52-week high.

On profitability, APYX generates a return on equity (ROE) of -76.49%, return on capital employed of -40.00%, an operating margin of -7.70%, a net profit margin of -16.40%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides